NCT04383431
Cross-linking as Treatment in Infectious Keratitis
Standard Cross-linking Versus Accelerated Photoactivated Chromophore Cross-linking (PACK-CXL) for Treatment of Infectious Keratitis: A Comparative Study
Sohag University·ClinicalTrials.gov·procedureRecruiting
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Infectious Keratitis
- Drug/Device/Intervention
- PACK-CXL
- Study type
- Interventional
- Intervention type
- procedure
Sponsor & location
- Primary sponsor
- Sohag University
- Location
- Sohag, Egypt
Timeline & enrollment
- Phase
- N/A
- Start date
- Jun 02, 2020
- End date
- Dec 01, 2023
- Enrollment
- 30 participants
Primary outcome
Corneal healing,Corneal edema
Summary
To compare between SCXL and ACXL for treatment of infectious keratitis
ICD-10 classifications
KeratitisKeratitis, unspecifiedOther keratitisHerpesviral keratitis and keratoconjunctivitisKeratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT04383431
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT04383431 through Pure Global AI's free database. This phase not specified trial is sponsored by Sohag University and is currently Recruiting. The study focuses on Infectious Keratitis. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.